These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 233550
21. Lipids and atherosclerosis. Havel RJ. Cardiovasc Res Cent Bull; 1977; 15(3):93-7. PubMed ID: 189927 [No Abstract] [Full Text] [Related]
22. [Metformin, lipids and atherosclerosis]. Joffroy-Lavieuville M, Triadou N, Noel M. Journ Annu Diabetol Hotel Dieu; 1984; ():361-6. PubMed ID: 6399538 [No Abstract] [Full Text] [Related]
23. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Devlin CM, Lee SJ, Kuriakose G, Spencer C, Becker L, Grosskopf I, Ko C, Huang LS, Koschinsky ML, Cooper AD, Tabas I. Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467 [Abstract] [Full Text] [Related]
24. The structure and metabolism of chylomicrons and very low density lipoproteins (VLDL). Levy RI, Bilheimer DW, Eisenberg S. Biochem Soc Symp; 1971 Aug; (33):3-17. PubMed ID: 4377703 [No Abstract] [Full Text] [Related]
25. [Metabolism of chylomicrons and very low density lipoproteins]. Windler E. Klin Wochenschr; 1990 Aug; 68 Suppl 22():19-22. PubMed ID: 2087074 [Abstract] [Full Text] [Related]
26. Lipoprotein physiology and its relationship to atherogenesis. Ginsberg HN. Endocrinol Metab Clin North Am; 1990 Jun; 19(2):211-28. PubMed ID: 2192871 [Abstract] [Full Text] [Related]
27. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference. Niu YG, Evans RD. Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778 [Abstract] [Full Text] [Related]
28. [Structure and metabolism of lipoproteins]. Beucler I, Salmon S, Petit E, Ayrault-Jarrier M, Polonovski J. Ann Biol Clin (Paris); 1986 Nov; 44(5):531-5. PubMed ID: 3544976 [Abstract] [Full Text] [Related]
29. Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport. Roheim PS. Am J Cardiol; 1986 Feb 12; 57(5):3C-10C. PubMed ID: 3511664 [Abstract] [Full Text] [Related]
32. Dissection of the complex role of apolipoprotein E in lipoprotein metabolism and atherosclerosis using mouse models. van Dijk KW, Hofker MH, Havekes LM. Curr Atheroscler Rep; 1999 Sep 11; 1(2):101-7. PubMed ID: 11122698 [Abstract] [Full Text] [Related]
33. [HDL and atherosclerosis (author's transl)]. Loutan L. Schweiz Rundsch Med Prax; 1979 Aug 28; 68(35):1109-10. PubMed ID: 228262 [No Abstract] [Full Text] [Related]
34. The plasma lipoproteins: current concepts of metabolism and structure with clinical implications. Gotto AM. Adv Exp Med Biol; 1978 Aug 28; 104():61-76. PubMed ID: 213956 [No Abstract] [Full Text] [Related]
35. McCollum Award Lecture, 1993: triglyceride-rich lipoproteins and atherosclerosis--new perspectives. Havel R. Am J Clin Nutr; 1994 Apr 28; 59(4):795-6. PubMed ID: 8147321 [No Abstract] [Full Text] [Related]
37. The influence of molecular biology on our understanding of lipoprotein metabolism and the pathobiology of atherosclerosis. Knecht TP, Glass CK. Adv Genet; 1995 Nov 28; 32():141-98. PubMed ID: 7741021 [No Abstract] [Full Text] [Related]
38. The endothelium, triglyceride-rich lipoproteins, and atherosclerosis: insights from cell biology and lipid metabolism. Fielding CJ. Diabetes; 1981 Nov 28; 30(Suppl 2):19-23. PubMed ID: 7297770 [Abstract] [Full Text] [Related]